Battling the Chimaera: How Much Disclosure of Rare Risks Is Necessary?
Publication
, Journal Article
Murillo Berlioz, A
Duke Scholars
Related Subject Headings
- United States
- Truth Disclosure
- Surgical Wound Infection
- Risk Assessment
- Respiratory System
- Practice Guidelines as Topic
- Policy Making
- Operating Rooms
- Mycobacterium Infections, Nontuberculous
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Murillo Berlioz, A. (n.d.). Battling the Chimaera: How Much
Disclosure of Rare Risks Is Necessary?
Murillo Berlioz, A. “Battling the Chimaera: How Much
Disclosure of Rare Risks Is Necessary?,” n.d.
Murillo Berlioz A. Battling the Chimaera: How Much
Disclosure of Rare Risks Is Necessary?
Murillo Berlioz, A. Battling the Chimaera: How Much
Disclosure of Rare Risks Is Necessary?
Murillo Berlioz A. Battling the Chimaera: How Much
Disclosure of Rare Risks Is Necessary?
Related Subject Headings
- United States
- Truth Disclosure
- Surgical Wound Infection
- Risk Assessment
- Respiratory System
- Practice Guidelines as Topic
- Policy Making
- Operating Rooms
- Mycobacterium Infections, Nontuberculous
- Humans